A COMMUNITY BASED STUDY, TO ESTIMATE PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME AND ITS CLINICAL SIGNIFICANCE, IN REPRODUCTIVE AGE WOMEN IN TELANGANA, SOUTH INDIA
Main Article Content
Keywords
Polycystic Ovarian Syndrome, Prevalence, Reproductive women, Clinical effects Introduction:
Abstract
: Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that often leads to irregular menstrual cycles, excessive hair growth on the face or body (hirsutism), and the presence of multiple cysts in the ovaries. Globally, its prevalence varies widely—from 2.2% to 26%—due in part to inconsistencies in diagnostic criteria. This community-based study aims to determine the accurate prevalence of PCOS among women of reproductive age (15–45 years) and to explore the associated health effects.
Materials and Methods: A cross-sectional study was conducted involving 500 women aged 15–45 years from a rural community. Data were collected through structured interviews and clinical examinations. Among these participants, 182 women who exhibited clinical signs suggestive of PCOS underwent further biochemical tests and pelvic ultrasound to confirm the diagnosis. The study also assessed the health effects associated with PCOS. Data analysis was performed using SPSS version 20.
Results: The prevalence of PCOS in the study population was found to be 14% (42 out of 300). Among the diagnosed cases, infertility was the most frequently reported complication, followed by psychosocial issues.
Conclusion: Although 76.1% of women diagnosed with PCOS reported experiencing infertility, only 23.8% had received any form of treatment, highlighting a significant gap in diagnosis and access to care in the community.
References
2. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992. pp. 377–384.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, authors. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
4. Azziz R, Carmina E, Dewailly D, Kandarakis E D, MorrealeH F E, Futterweit W et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
5. S.J. Ramanand, B.B. Ghongane, J.B. Ramanand, Milind H P, Ravi R G, Suyog S Jain. Clinical characteristics of polycystic ovary syndrome in Indian women, Indian J. Endocrinol. Metab. 2013;17 (1) : 138–145.
6. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-30.
7. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation Geneva, 8–11 December 2008 Available at http://whqlibdoc.who.int/publications/2011/ 9789241501491_eng.pdf
8. Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, et,al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod. 2014 ;29(4):791-801.
9. Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019 ;150(4):333-344.
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donator KA, et al., Harmonizing the Metabolic Syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study Of Obesity. Circulation 2009;120(16):1640-5.
11. Vidya Bharathi R, Swetha S, Neerajaa J, Varsha Madhavica J, Janani DM, Rekha SN, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J 2017; 22 (4) : 313-6.
12. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011; 24(4) : 223-7.
13. Balaji S, Amadi C, Prasad S, Bala Kasav J, Upadhyay V, Singh AK, et al. Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India. Biomed Res Int 2015; 2015 : 158951.
14. Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab 2014; 18 (3) : 317-24.
15. Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene. Indian J Endocrinol Metab. 2019;23(3):326-331.
16. Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study. Int J Gynaecol Obstet. 2020 May;149(2):231-236.
17. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011: 25;9:39.
18. Abid K, Shah IH, Sheikh G Cutaneous manifestations of polycystic ovary syndrome: a cross sectional clinical study. Indian Dermatol Online J. 2017; 8(2):104–110
19. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1357–1363
20. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020;13(4):261-271.
21. Deswal R, Nanda S, Ghalaut VS, Roy PS, Dang AS. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations. Int J Gynaecol Obstet 2019;146(3):370-9.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Karunasri Karapati
MBBS, MS (OBG), MRCPI, MRCOG. Consultant In Department of Gynaecology and obstetrics, Xenia hospitals, Hyderabad, telangana.
Dr. Sunitha Ravirala
MBBS, DGO, MRCOG, Chief medical officer, ESIC medical college, Sanath Nagar, Hyderabad, Telangana, India.
Dr. Doddoju Veera Bhadreshwara Anusha
MBBS, MD, Professor, Department of Community Medicine, RVM institute of medical sciences and research centre.